Cigna Reports Strong Fourth Quarter and Full Year 2022 Results, Establishes 2023 Guidance and Increases Dividend BioSpaceCigna expects revenue gains from launches of Humira biosimilars Medical DialoguesView Full Coverage on Google News Source link